<DOC>
	<DOC>NCT00169546</DOC>
	<brief_summary>Comparison of two asthma treatments by lung function measures.</brief_summary>
	<brief_title>Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.</brief_title>
	<detailed_description />
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate, Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Inclusion criteria: Currently receiving 200800mcg/day beclomethasone dipropionate. sRAW value of 1.3 kPa's. 3 or more courses of oral steroids in last 12 months.</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>inhaled corticosteroids</keyword>
</DOC>